Neurological disorders

Julie Frates carries her daughter Lucy as they follow the casket of her husband Pete Frates following his funeral at St. Ignatius of Loyola Parish church at Boston College in Boston, Friday, Dec. 13, 2019. Frates, a former college baseball player whose determined battle with Lou Gehrig's disease helped inspire the ALS ice bucket challenge that has raised more than $200 million worldwide. (AP Photo/Charles Krupa)
December 13, 2019 - 3:23 pm
BOSTON (AP) — To honor Peter Frates — the former Boston College baseball player whose public battle with ALS helped make the ice bucket challenge a phenomenon — do as he did, the priest who officiated at his funeral said Friday. “The best way to honor him is to try to imitate him,” the Rev. Tony...
Read More
Julie Frates carries her daughter Lucy as they follow the casket of her husband Pete Frates following his funeral at St. Ignatius of Loyola Parish church at Boston College in Boston, Friday, Dec. 13, 2019. Frates, a former college baseball player whose determined battle with Lou Gehrig's disease helped inspire the ALS ice bucket challenge that has raised more than $200 million worldwide. (AP Photo/Charles Krupa)
December 13, 2019 - 2:04 pm
Read More
Julie Frates carries her daughter Lucy as they follow the casket of her husband Pete Frates following his funeral at St. Ignatius of Loyola Parish church at Boston College in Boston, Friday, Dec. 13, 2019. Frates, a former college baseball player whose determined battle with Lou Gehrig's disease helped inspire the ALS ice bucket challenge that has raised more than $200 million worldwide. (AP Photo/Charles Krupa)
December 13, 2019 - 1:30 pm
Read More
In this Nov. 22, 2019, photo, Charles Flagg, who is stricken with Alzheimer's disease, receives the contents of an intravenous bag while participating in a study on the drug Aducanumab at Butler Hospital in Providence, R.I. New results were released on the experimental medicine whose maker claims it can slow the decline of Alzheimer's disease, the most common form of dementia. (AP Photo/Charles Krupa)
December 05, 2019 - 3:20 pm
SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday but left them sharply divided over whether there’s enough evidence of effectiveness for the medicine to warrant federal approval. Excitement and...
Read More
December 05, 2019 - 12:08 pm
SAN DIEGO (AP) — A company that claims to have the first drug to slow mental decline from Alzheimer's disease made its case to scientists Thursday, disclosing more results that may help explain why one study of the experimental medicine succeeded and another failed. Excitement and skepticism have...
Read More
This undated photo provided by Acadia Pharmaceuticals Inc. shows a bottle of Nuplazid, a drug that was tested for treating psychosis related to dementia. If regulators agree, the drug could become the first treatment specifically for dementia-related psychosis and the first new medicine for Alzheimer's in nearly two decades. Results from a study on the drug were disclosed Wednesday, Dec. 4, 2019, at an Alzheimer's conference in San Diego. (Acadia Pharmaceuticals Inc. via AP)
December 04, 2019 - 8:53 pm
SAN DIEGO (AP) — A drug that curbs delusions in Parkinson's patients did the same for people with Alzheimer's disease and other forms of dementia in a study that was stopped early because the benefit seemed clear. If regulators agree, the drug could become the first treatment specifically for...
Read More
November 29, 2019 - 3:51 pm
NEW YORK (AP) — The number of major leaguers allowed to use otherwise-banned drugs to treat Attention Deficit Hyperactivity Disorder dropped to the lowest level since the sport started issuing annual reports in 2008. The results come in a report issued Monday by Thomas Martin, the Independent...
Read More
FILE - In this Nov. 6, 2015 file photo, an elderly couple walks down a hall in Easton, Pa. Research released on Friday, Nov. 1, 2019 suggests many American adults inaccurately estimate their chances for developing dementia and do useless things to prevent it. (AP Photo/Matt Rourke, File)
November 15, 2019 - 12:53 pm
Many older American adults may inaccurately estimate their chances for developing dementia and do useless things to prevent it, new research suggests. Almost half of adults surveyed believed they were likely to develop dementia. The results suggest many didn’t understand the connection between...
Read More
November 12, 2019 - 5:40 pm
SAN FRANCISCO (AP) — Billionaire philanthropists Joan and Sandy Weill announced Tuesday they are donating $106 million to launch a research initiative at three West Coast universities aimed at finding treatments for brain disorders like epilepsy and Alzheimer's disease. The donation to the...
Read More
FILE - In this Aug. 14, 2018 file photo, Dr. William Burke goes over a PET brain scan at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. says it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia. The announcement Tuesday, Oct. 22, 2019, is a surprise because the company earlier this year stopped two studies of the drug, called aducanumab, after partial results suggested it was not working. (AP Photo/Matt York, File)
October 22, 2019 - 6:44 pm
Biogen Inc. said Tuesday it will seek federal approval for a medicine to treat early Alzheimer's disease, a landmark step toward finding a treatment that can alter the course of the most common form of dementia. The announcement was a surprise because the drug company earlier this year stopped two...
Read More

Pages